JPH02167053A - Method for blending food consisting of dietary fiber of polysaccharides or the like - Google Patents
Method for blending food consisting of dietary fiber of polysaccharides or the likeInfo
- Publication number
- JPH02167053A JPH02167053A JP63318643A JP31864388A JPH02167053A JP H02167053 A JPH02167053 A JP H02167053A JP 63318643 A JP63318643 A JP 63318643A JP 31864388 A JP31864388 A JP 31864388A JP H02167053 A JPH02167053 A JP H02167053A
- Authority
- JP
- Japan
- Prior art keywords
- dietary fiber
- composition
- yeast
- day
- constipation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013325 dietary fiber Nutrition 0.000 title claims abstract description 55
- 150000004676 glycans Chemical class 0.000 title claims abstract description 8
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 8
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 8
- 238000002156 mixing Methods 0.000 title claims abstract description 5
- 235000013305 food Nutrition 0.000 title claims description 10
- 238000000034 method Methods 0.000 title claims description 4
- 239000000203 mixture Substances 0.000 claims abstract description 42
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 20
- 238000013329 compounding Methods 0.000 claims description 2
- 206010010774 Constipation Diseases 0.000 abstract description 17
- 208000024891 symptom Diseases 0.000 abstract description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 17
- 230000000694 effects Effects 0.000 description 15
- 210000003608 fece Anatomy 0.000 description 10
- 230000033001 locomotion Effects 0.000 description 9
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 8
- 241000282326 Felis catus Species 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 6
- 239000001913 cellulose Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 229920001100 Polydextrose Polymers 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000001259 polydextrose Substances 0.000 description 4
- 229940035035 polydextrose Drugs 0.000 description 4
- 235000013856 polydextrose Nutrition 0.000 description 4
- 206010013554 Diverticulum Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000792859 Enema Species 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000007920 enema Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 208000004840 megacolon Diseases 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010011091 Coronary artery thrombosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 208000002528 coronary thrombosis Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 229940079360 enema for constipation Drugs 0.000 description 1
- 230000010006 flight Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【発明の詳細な説明】
イ、発明の目的
産業上の利用分野
本発明は、食品産業分野で予防医学上の食事補従来の技
術
従来の技術は、不溶性食物繊維を主とする食品や、可溶
性食物繊維を含有する飲料などの単種品目の食物繊維の
利用や、栄養剤としての酵母の利用などに限られていた
。DETAILED DESCRIPTION OF THE INVENTION B. Purpose of the Invention Industrial Field of Application The present invention is used in the food industry to provide dietary supplements for preventive medicine. The use of dietary fiber in single items such as beverages containing dietary fiber and the use of yeast as nutritional supplements have been limited.
本発明は、そのために生じつつある課Ｕの解決を目標と
している。The present invention aims to solve the problem U that is arising accordingly.
発明が解決しようとする課題
多糖類食物繊維が現代病発生の問題上に採り上げられて
以来、食品分野の各方面に利用されて来たが、不溶性食
物繊維の保水性の高い物質の単品種のみを多く抛って、
大腸内で腸丙容物が膨潤して便秘がひどくなったり、積
取後の食生活のリズムが狂ったり、拒食症を発生するな
どの実例が見られた。又、可溶性食物繊維を多く含む飲
料の使用で脂肪積取の抑制効果は認められるが、便秘や
腸内有益菌の増殖による腸内浄化などに、その作用効果
が及ばないことが見られた。Problems to be Solved by the Invention Ever since polysaccharide dietary fiber was taken up as a problem in modern disease development, it has been used in various fields in the food field, but only a single variety of insoluble dietary fiber with high water retention has been developed. Take a lot of
There have been cases where the contents of the intestines swell in the large intestine, resulting in severe constipation, disruption of the eating rhythm after removal, and anorexia. Furthermore, although the use of beverages containing a large amount of soluble dietary fiber was found to have an effect of suppressing fat accumulation, it was found that the effects were not effective in preventing constipation and intestinal cleansing due to the proliferation of beneficial intestinal bacteria.
本発明者は、これに対して多糖類食ｆＩｌ繊維の多種類
品目の複合による効果の検討を行って来た。In response to this, the present inventor has investigated the effects of combining multiple types of polysaccharide dietary fl fibers.
本発明は、単品使用の問題点を解決するために特許請求
の範囲第１項の配合の手段を完成して、その実施によっ
ているいろな効果例を見た。誘過の便秘は、第１項の発
明で大抵は対応できるが、たまには、通便の効果が不充
分なこともあるために一層の効果の向上を示す組成の完
成が求められ特許請求の範囲第２項の配合による組成物
を完成して、その実施による効果例が見られた。In order to solve the problem of single product use, the present invention has completed the compounding means of claim 1, and various examples of effects obtained by its implementation have been obtained. Induced constipation can be treated in most cases by the invention set forth in item 1, but sometimes the effect on defecation is insufficient, so it is desired to complete a composition that shows further improvement in the effect. A composition according to the formulation described in Section 2 was completed, and examples of the effects achieved by its implementation were observed.
口、発明の構成
課題を解決するための手段
本発明の課題を解決するための手段として、組成物の構
成素材の配合について、鋭意、研究を行い以下の結果を
得た。Means for Solving the Constituent Problems of the Invention As a means for solving the problems of the present invention, we conducted intensive research on the formulation of the constituent materials of the composition and obtained the following results.
特許請求の範囲第１項の配合
不溶性食物繊維の配合の構成は下限が７５％、可溶性食
物繊維の配合の構成は上限が２５％である。The lower limit of the insoluble dietary fiber composition in claim 1 is 75%, and the upper limit of the soluble dietary fiber composition is 25%.
不溶性食物繊維は糞便の嵩をますが、その保水性は腸管
から吸収され、便はカスカスの便となるので時には腸管
内の便の移動が不充分となるために、不溶性食物繊維の
配分を減らして可溶性食物繊維の配分を増すことで、糞
便の保水力を維持して通便のスムーズな移動が可能とな
るが、その配合を、不溶性食物ｌａ＃！を７５％以下と
することで糞便の嵩は減じ、相対的に可溶性食物繊維が
２５％以上となって、糞便は必要以上に水分を増すため
に、便は、細長く、切れ目が生じ、ベトついた便となっ
て、排便に困難となり、残便が生じる結果が見られた。Insoluble dietary fiber adds bulk to feces, but its water-retaining properties allow it to be absorbed from the intestinal tract, resulting in cascading stools that sometimes result in insufficient movement of feces through the intestinal tract, reducing the distribution of insoluble dietary fiber. By increasing the distribution of soluble dietary fiber, it is possible to maintain the water retention capacity of feces and allow smooth movement of the stool. By reducing the amount of feces to 75% or less, the bulk of the feces is reduced, and the relative soluble dietary fiber content is 25% or more, which increases the water content of the feces more than necessary, making the feces elongated, cut, and sticky. The result was that the stool became dry, making it difficult to defecate, and resulting in residual stool.
そのために、特許請求の範囲第１項の配合で、不溶性食
物繊維の配合の下限が７５％、可溶性食物繊維の配合の
上限を２５％として組成して、通便の検討を行った。To this end, the formulation according to claim 1 was formulated with a lower limit of insoluble dietary fiber of 75% and an upper limit of soluble dietary fiber of 25%, and examination of bowel movements was conducted.
また、不溶性食物繊維の配合の上限を９５％とし、可溶
性食物繊維の配合の下限を５％とした。Furthermore, the upper limit of the insoluble dietary fiber content was set at 95%, and the lower limit of the soluble dietary fiber content was set at 5%.
不溶性食物繊維の配合を９５％以上に対して、可溶性食
物繊維を５％以下の配合とすると、便の嵩は増してカス
カスの太い便となり、水分含有量は少なくなるため、腸
管内や肛門口でつまることが多く見られた。If the proportion of insoluble dietary fiber is 95% or more and the soluble dietary fiber is 5% or less, the bulk of the stool will increase, making it thick and crinkly, and the water content will be low, which will cause the intestines and anus to become more bulky. I saw a lot of things getting stuck.
そのため、不溶性食物繊維を９５％にとどめて相対的に
可溶性食物繊維の配合を５％として、便の水分含有量を
増して、便の腸管円移動が容易になった。Therefore, by keeping the insoluble dietary fiber at 95% and relatively increasing the soluble dietary fiber to 5%, the water content of the stool was increased and the movement of the stool through the intestinal tract was facilitated.
特許請求の範囲第２項の配合
特許請求の範囲第１項の配合の組成物では、たまには神
経性の便秘などで、肛門口に少しでも固まりができると
、直腸内の糞便は、食物繊維で増量した分量のため却っ
て多量の停滞となり、下腹部は著しく膨満して苦痛を伴
い、また、腸管内に於ける便の移動の活発でない老人性
便秘や現代病の家庭療養者の便秘などにも、充分な効果
が見られないこともある。このために、本発明は、多糖
類食物繊維の多種類の配合に酵母を配合して、その効果
の検討を行った。The combination of Claim 2 With the composition of Claim 1, if even a slight lump forms in the anus orifice due to nervous constipation, the feces in the rectum will be reduced in dietary fiber. Due to the increased volume, a large amount stagnates, and the lower abdomen becomes noticeably swollen, causing pain. It can also be used for senile constipation due to lack of active stool movement in the intestinal tract, and for constipation in home care patients suffering from modern diseases. , sufficient effects may not be seen. To this end, in the present invention, yeast was added to various combinations of polysaccharide dietary fibers, and the effects thereof were investigated.
特許請求の範囲第２項の配合では、多種類食物繊維の組
成物の配合の上限を９０％、＃母の配合の下限を１０％
とした。In the formulation of claim 2, the upper limit of the blend of the multi-type dietary fiber composition is 90%, and the lower limit of the #mother blend is 10%.
And so.
多種類食物繊維を９０％以上とし、対するに酵母を１０
％以下とすると、事項冒頭に述べた症状に対する効果は
不充分となり、酵母の作用効果が充分に現れない。その
ために、多種類食物繊維を上限９０％の配合とし、酵母
の配合を下限１０％とした。Contains over 90% of various types of dietary fiber, and 10% of yeast.
% or less, the effect on the symptoms mentioned at the beginning of the item will be insufficient, and the action and effect of yeast will not be fully manifested. To this end, the upper limit of the multi-type dietary fiber content was 90%, and the lower limit of the yeast content was 10%.
また、多種類食物繊維の組成物の配合を６０％をＦ限と
し、酵母の配合の上限を４０％とした。Further, the F limit for the composition of the multi-type dietary fiber composition was set at 60%, and the upper limit for the composition of yeast was set at 40%.
多種類食物繊維の組成物の配合を６０％以下とし、対す
るに酵母の配合を４０％以上にすると、糞便の嵩は減じ
、保水力も低下し、便は細長い形状となり、切れ目のあ
る状態となって、残便を生じることとなった。これでは
、第２項の配合の意味を失くすることになる。When the composition of multi-type dietary fiber is 60% or less and the yeast composition is 40% or more, the volume of feces decreases, the water retention capacity decreases, and the feces become elongated and cut. This resulted in some leftover stool. In this case, the meaning of the formulation in the second term will be lost.
以上の研究の結果、多糖類食物繊維の多種類の複合によ
る組成物を８０％〜７０％、酵母を２０％〜３０％の配
合の構成にすることで、前述の便秘や便の移動に於ける
症状に対して、最も好ましい配合と考えられる。As a result of the above research, we found that by creating a composition containing 80% to 70% of a composite of various types of polysaccharide dietary fibers and 20% to 30% of yeast, we were able to alleviate the aforementioned constipation and stool movement. This combination is considered to be the most preferable for the symptoms associated with this disease.
酵母は醸造用酵母を使用した。The yeast used was brewer's yeast.
以下の実施例で、実施例１、同２の項では、特許請求の
範囲第１項の組成物の実施例を述べた。In the following Examples, Examples 1 and 2 describe examples of the composition of Claim 1.
作用
不溶性食物ＨＡ維は、便のゲル化を促進し、嵩を増して
、太い切れ目のないカスカスの便をつくるが、腸壁の吸
水の機能に対して便の保水力を保つには不充分である。Effect: Insoluble dietary HA fibers promote gelatinization of stools, increase their bulk, and create thick, unbroken cascades of stools, but are insufficient to maintain the water-retaining capacity of stools against the water-absorbing function of the intestinal wall. It is.
そのために、可溶性食物繊維を適当な割合で配合するこ
とで、腸管内移動に適当な便の保水力が得られると考え
られる。更に酵母を加えることで、便の停滞や便秘に対
する効果が一段と向上したのは、酵母による便の物性改
善だけでなく、腸内有益菌叢の増殖がかかわっていると
考えられる。Therefore, by incorporating soluble dietary fiber in an appropriate proportion, it is thought that water retention capacity of stool suitable for movement in the intestinal tract can be obtained. Furthermore, the addition of yeast further improved the effect on stool stagnation and constipation, which is thought to be due not only to the improvement of the physical properties of stool by the yeast, but also to the proliferation of beneficial intestinal flora.
以下の実施例で本発明の効用を示す。なお、本発明の実
施例においては、不溶性食物繊維はセルローズ、可溶性
食物繊維はポリデキストロ、−ス、実施例１
１、対象、男性６４才、肥満タイプ。冠動脈血栓症で６
ケ月後の手術を控えたホームケアの食事補正として実施
。The following examples demonstrate the utility of the invention. In the examples of the present invention, the insoluble dietary fiber is cellulose, and the soluble dietary fiber is polydextro.Example 1 1. Subject, male, 64 years old, obese type. 6 due to coronary thrombosis
Implemented as a dietary correction for home care in preparation for surgery in a few months.
２、不溶性食物繊維９３％、可溶性食物繊維７％の組成
物を毎回３グラム、牛乳にまぜて１日３回とる。2. Take 3 grams of a composition of 93% insoluble dietary fiber and 7% soluble dietary fiber, mixed with milk, three times a day.
３、従来は軟便と便秘の状態の交互の繰返しがつづいて
いた。実施後、徐々に切れ目の少ない、太く長い便の毎
日となった。ただ、月間に１〜２回程の４８時間位の便
の停滞がある。3. In the past, patients continued to alternate between having loose stools and being constipated. After implementation, I gradually started having thicker, longer stools with fewer breaks. However, flights are delayed for about 48 hours once or twice a month.
実施例２
１、対象、女性、３０才代、１０年来、顔−面に腫物様
の吹出物が治らず、時々腹部に痛痒を感じる。憩室症と
診断された。便秘。Example 2 1. Subject, female, in her 30s, has had swelling-like eruptions on her face that have not healed for the past 10 years, and sometimes feels itching in her abdomen. He was diagnosed with diverticulosis. constipation.
２、不溶性食物繊維セルローズ７５％、可溶性食物繊維
ポリデキストロース２５％の配合による組成物（憩室症
への対応のためポリデキストロースを増量し、便の重み
を増すようにした。）を、実施直後の１ケ月間は毎回３
．５グラム、それ以降は毎回３グラムを中国茶にまぜて
１日３回とる。2. A composition containing 75% insoluble dietary fiber cellulose and 25% soluble dietary fiber polydextrose (the amount of polydextrose was increased to cope with diverticulosis to increase the weight of stool) was applied immediately after implementation. 3 each time for 1 month
．． Take 5 grams, then 3 grams each time, mixed with Chinese tea, three times a day.
３゜実施？＆５０日目からＩ！ ！１１が徐々に縮小し
、３ケ月後には全く解消し、憩室がなくなっていると診
断された。同時に、習慣性便秘が解消した。ただ、少し
ベトつき気味の便でそのために、１日に３〜４回の排便
となっている。3゜implementation? & I from the 50th day! ! 11 gradually decreased in size, and three months later, it completely disappeared, and it was diagnosed that the diverticulum was gone. At the same time, habitual constipation was resolved. However, his stools are a bit sticky, which is why he has to defecate 3 to 4 times a day.
以下の実施例では、特許請求の範囲第２項の実施例を述
べた。In the following embodiments, embodiments according to claim 2 have been described.
実施例３ １、対象、女性、６０才代。生来の重度の便秘症。Example 3 1.Target: Female, in her 60s. Congenital severe constipation.
５０才代ｆ！ ’４’から白内障にかかり、現在は全盲
に近い。50s f! He developed cataracts from the age of 4, and is now nearly completely blind.
２、不溶性食９１ ｊＭ帷セルローズ６０％、水溶性食
物繊維ポリデキストローズｌＯ％、酵母３０％を配合し
た組成物にハチミツを加えて半ネリ状として、１日に１
回、約８グラムをとる。2. Insoluble Food 91 jM Thread A composition containing 60% cellulose, 10% water-soluble dietary fiber polydextrose, and 30% yeast is added with honey to form a semi-nellie-like mixture and consumed once a day.
Take about 8 grams at a time.
３、実施１ケ月後から、排便は１日に１〜２回となり、
悪臭のない快便となる。3. After 1 month of implementation, defecation will be 1 to 2 times a day,
It provides a comfortable stool without any bad odor.
実施例４
１、対象、女性、２０才代。顔−面にニキビ吹出物があ
り、便秘症。Example 4 1. Subject, female, in her 20s. I have acne breakouts on my face and constipation.
２、不溶性食物ｍｕセルローズ６５％、可溶性食物繊維
１５％、酵母２０％を配合した組成物を、毎回３．５グ
ラムを牛乳にまぜて、１日３回とる。2. Mix 3.5 grams of a composition containing 65% insoluble food mu cellulose, 15% soluble dietary fiber, and 20% yeast in milk and take three times a day.
３、実施ｆ＆ １５日程で、ニキビ吹出物が激減し、便
秘も徐々に解消した。１日２回の排便で悪臭なし。切れ
目少し。3. After 15 days of implementation, acne breakouts decreased dramatically and constipation gradually disappeared. There is no bad odor when defecating twice a day. A little cut.
実施例５
１、対象、女性、５０才代。肥満で下半身が水太り現象
ひどく便秘症。Example 5 1. Subject, female, in her 50s. I am obese and my lower body becomes watery and I suffer from severe constipation.
２、不溶性食物繊維７０％、可溶性食物繊維１゜％、酵
母２０％を配合した組成１勿を、毎回３グラムを中国茶
にまぜて、１日３回とる。2. Mix 3 grams of the composition 1 Mu, which contains 70% insoluble dietary fiber, 1% soluble dietary fiber, and 20% yeast, with Chinese tea and take it three times a day.
３、実施１ケ月を経て、体重１．５キログラムの減量が
見られて下゛終身のむくみ現象が改善され、従来の軟便
か便秘による兎貴状の便がというくり返しの状態が解消
した。3. After one month of implementation, a weight loss of 1.5 kg was observed, the permanent swelling of the lower abdomen was improved, and the repeated condition of having soft stools or rabbit-like stools due to constipation was resolved.
以下の実施例は、特許請求の範囲第２項の組成物を、小
動物に適用した例である。The following examples are examples in which the composition of claim 2 was applied to small animals.
実施例６
１、対象、大ヨークシャテリヤ種オス２才。胃潰瘍、ノ
イローゼで動物病院に入院。食欲なく、排便もタール状
の便に近い状態となる。Example 6 1. Subject: 2-year-old male large Yorkshire terrier. He was admitted to a veterinary hospital with stomach ulcer and neurosis. There is no appetite, and the stools are almost tar-like.
２、不溶性食物繊維セルローズ６６％、可溶性食物繊維
ポリデキストロース１２％、酵母２２％の配合の組成物
を、１日に１回、１グラムをカプセルに入れて与えた。2. One gram of a composition containing 66% insoluble dietary fiber cellulose, 12% soluble dietary fiber polydextrose, and 22% yeast was given in a capsule once a day.
５日目から同量を牛乳にまぜて与えた。From the 5th day, the same amount was mixed with milk and given.
３、実施３日目から食欲が出て徐々に元気を取戻した。3. From the third day onwards, my appetite started to improve and I gradually regained my energy.
便もだんだんと型状がととのって来て、１００日目ら毎
日の排便がみられた。The shape of his stools gradually improved, and he was able to defecate every day from the 100th day onward.
実施例７
事項では、不溶性食物繊維セルローズ５７％、可溶性食
物繊維１８％、酵母２５％の組成１勿を、猫に投与した
例を述べる。In Example 7, an example will be described in which a composition containing 57% insoluble dietary fiber cellulose, 18% soluble dietary fiber, and 25% yeast was administered to cats.
１．１週間排便のない日本猫に１日１回、０．５グラム
を牛乳にまぜて与えた。３日目から毎日きぼらないでス
ムーズに便がでるようになった。1. A Japanese cat that had not defecated for a week was given 0.5 grams mixed with milk once a day. From the third day onwards, I was able to have smooth bowel movements without straining every day.
２、巨大結局症の手術をしたベルジャ猫が、２〜３ケ月
後から排便が思わしくなく、再び巨大結局症のおそれが
生じたので、０．５グラムの本組成物を、１日に１回、
食餌にまぜて与えたところ、排便がスムーズに行なわれ
るようになった。2. After 2 to 3 months of surgery for megacoccysis, Belja's cat was having trouble defecating and there was a risk of macrococcysis again, so I applied 0.5g of this composition once a day. ,
When I mixed it with my food and gave it to them, my bowel movements became smoother.
３、巨大結腸症の日本猫。コーラツクで排便させ、１ケ
月に１度の浣腸を必要としていたが、本組成物を毎日１
回０．５グラムを食餌にまぜて与えたところ、排便が順
調となり、浣腸も不要になった。3. Japanese cat with megacolon. The patient had to defecate with Koratsuk and needed to take an enema once a month, but after taking this composition once a day.
When I gave him 0.5g per meal mixed with his food, his defecation became smooth and he no longer needed enemas.
４、巨大結腸症の初期で、排便に１〜２日かかった日本
猫に、１日１回０．５グラムの本組成物を食餌にまぜて
与えたところ、順調に排便が見られるようになった。4. When a Japanese cat was in the early stages of megacolon and took 1 to 2 days to defecate, 0.5 g of this composition was given once a day by mixing it with the food, and the cat defecated smoothly. became.
ハ、発明の効果
本発明は、特許請求の範囲第１項、同第２項の配合の技
術による組成物を、食事の補正食として利用することに
より、現代病対策とくに便秘およびそれに伴って現れる
症状の改善のために充分な効果をもっている。C. Effects of the Invention The present invention provides measures against modern diseases, particularly constipation and its accompanying effects, by using the composition according to the formulation techniques set forth in claims 1 and 2 as a dietary correction food. It is effective enough to improve symptoms.
特許出願人の氏名 吉相 明孝Patent applicant name: Akitaka Kisou
Claims (1)
の全重量のうち、不溶性食物繊維を７５重量％〜９５重
量％、可溶性食物繊維を５重量％〜２５重量％を配合し
て組成する多種類食物繊維の配合の方法。 ２、特許請求の範囲第１項の多糖類食物繊維の組成に酵
母を配合した組成物の全重量のうち、多糖類食物繊維の
組成物を９０重量％〜６０重量％、酵母を１０重量％〜
４０重量％を配合して組成する食品の配合の方法。[Claims] 1. Of the total weight of the composition containing insoluble dietary fiber and soluble dietary fiber, insoluble dietary fiber accounts for 75% to 95% by weight, and soluble dietary fiber accounts for 5% to 25% by weight. A method of blending and composing multiple types of dietary fiber. 2. Of the total weight of the composition in which yeast is blended with the polysaccharide dietary fiber composition of Claim 1, the polysaccharide dietary fiber composition is 90% to 60% by weight, and the yeast is 10% by weight. ~
A method of compounding a food by blending 40% by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63318643A JPH02167053A (en) | 1988-12-19 | 1988-12-19 | Method for blending food consisting of dietary fiber of polysaccharides or the like |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63318643A JPH02167053A (en) | 1988-12-19 | 1988-12-19 | Method for blending food consisting of dietary fiber of polysaccharides or the like |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH02167053A true JPH02167053A (en) | 1990-06-27 |
Family
ID=18101427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63318643A Pending JPH02167053A (en) | 1988-12-19 | 1988-12-19 | Method for blending food consisting of dietary fiber of polysaccharides or the like |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH02167053A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60262572A (en) * | 1984-06-04 | 1985-12-25 | ワーナー―ランバート・コンパニー | Dietary fiber composition and its production |
| JPS60262573A (en) * | 1984-06-04 | 1985-12-25 | ワ−ナ−−ランバ−ト・コンパニ− | Dietary fiber food and its production |
-
1988
- 1988-12-19 JP JP63318643A patent/JPH02167053A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60262572A (en) * | 1984-06-04 | 1985-12-25 | ワーナー―ランバート・コンパニー | Dietary fiber composition and its production |
| JPS60262573A (en) * | 1984-06-04 | 1985-12-25 | ワ−ナ−−ランバ−ト・コンパニ− | Dietary fiber food and its production |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4511561A (en) | Laxative composition comprising psyllium seeds and senna fruits | |
| KR100516532B1 (en) | Inulin Products with Improved Nutritional Properties | |
| JP2002508772A (en) | Health supplement | |
| JP2002522491A (en) | Pharmaceutical compositions containing lipase inhibitors | |
| CN101416747A (en) | A kind of solid low-energy food that is rich in dietary fiber and preparation method thereof | |
| CN101683477A (en) | Composition for fat-reducing | |
| CN102524639A (en) | Fruit and vegetable fiber chewable tablet with defaecation and health care functions and preparation method thereof | |
| CN104489462A (en) | Xylooligosaccharide probiotic powder | |
| CN106260534A (en) | A kind of marmoset artifical compound feed | |
| JPH05255097A (en) | Liquid composition | |
| CA1167769A (en) | Laxative composition comprising psyllium seeds and senna fruits and method for the preparation thereof | |
| RU2343724C1 (en) | Method of manufacturing biologically active products from brown algae | |
| JPH02167053A (en) | Method for blending food consisting of dietary fiber of polysaccharides or the like | |
| DE69232126T3 (en) | Ingestible preparations containing water-soluble, highly viscous cellulose ethers | |
| JP2003055249A (en) | Nutrition supplement | |
| JPH07118162A (en) | Oral administration composition for livestock | |
| WO2014165971A1 (en) | Topical nutraceutical composition | |
| JPH08503926A (en) | Sugar-free dry mix cellulose ether composition as bulk laxative | |
| JP2676527B2 (en) | Molds for improving constipation, facilitating bowel movements, and improving fecal properties | |
| CN1138296A (en) | Use of dimeticone for treating constipation | |
| JPS6150919A (en) | Remedy for constipation of man and animal | |
| CN109221903A (en) | A kind of auxiliary defaecation and the meal replacement powder of norcholesterol and its preparation method and application | |
| JP2008188006A (en) | Sweetener | |
| CN102698144B (en) | Traditional Chinese medicine composition for treating gasteremphraxis | |
| Pemberton | THE METABOLISM AND SUCCESSFUL TREATMENT OF CHRONIC JOINT DISEASE: A PRELIMINARY REPORT. |